Skip to main content
. 2020 Oct 13;159(1):85–92. doi: 10.1016/j.chest.2020.10.009

Table 2.

Univariate Clinical Outcomes by Treatment Group

Outcome Unmatched Cohort
Matched Cohort
Control Subjects (n = 107) Ivermectin (n = 173) OR or Difference (95% CI) P Value Control Subjects (n = 98) Ivermectin (n = 98) OR or Difference (95% CI) P Value
Mortality . . . . . . . . . . . . . . . . . . . . . . . .
 Total 27 (25.2) 26 (15.0) 0.52 (0.29-0.96) 0.03 24 (24.5) 13 (13.3) 0.47 (0.22-0.99) 0.045
 Severe 21/26 (80.7) 19/49 (38.8) 0.15 (0.05-0.47) 0.001 18/22 (81.8) 8/25 (32.0) 0.27 (0.08-0.92) 0.002
 Nonsevere 6/81 (7.4) 7/124 (5.6) 0.75 (0.24-2.3) 0.61 6/76(7.9) 4/74 (5.4) 0.97 (0.61-1.54) 0.78
Successful extubation 4/26 (15.4) 13/36 (36.1) 3.11 (0.88-11.00) 0.07 3/22 (15.4) 7/18 (38.9) 1.91 (0.43-8.46) 0.14
Length of stay 7.0 (4.0-10.0) 7.0 (4.0-13.3) 0 (-1 to 2) 0.34 7.0 (4.0-10.0) 7.0 (3.0-13.0) 0 (-2 to 1) 0.88

Data are presented as No./Total No. (%) or median (interquartile range) unless otherwise indicated.